• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名被监禁患者的非典型抗精神病药恶性综合征:这是一个可能风险增加的人群。

Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk.

作者信息

Zabel Matthew, Kandukuri Rajeev

机构信息

College of Osteopathic Medicine, Rocky Vista University College of Osteopathic Medicine, Parker, Colorado, USA

Psychiatry, Parkview Medical Center, Pueblo, Colorado, USA.

出版信息

BMJ Case Rep. 2024 Feb 6;17(2):e257563. doi: 10.1136/bcr-2023-257563.

DOI:10.1136/bcr-2023-257563
PMID:38320820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10860020/
Abstract

An incarcerated male patient with a psychiatric history of schizoaffective disorder presented to the emergency department with muscle rigidity and mutism after receiving a 150 mg haloperidol decanoate injection. At the peak of his illness, symptoms included muscular rigidity, mutism, excessive drooling, an altered level of consciousness, tachycardia, diaphoresis and tremors. Atypical neuroleptic malignant syndrome (NMS) was diagnosed after discrediting similar illnesses through clinical reasoning, laboratory and imaging studies. He was successfully treated during a 40-day hospitalisation with lorazepam, amantadine, methocarbamol and supportive care. This case represents an atypical presentation of NMS due to the patient's lack of fever development. Nonetheless, he satisfied many other criteria, most notably rapid symptom onset after receiving a first-generation antipsychotic medication. The case also provides an opportunity to discuss the prevalence of psychiatric illness among the US incarcerated population and incarceration as a risk factor for developing NMS.

摘要

一名患有分裂情感性障碍精神病史的男性囚犯,在接受150毫克癸酸氟哌啶醇注射后,因肌肉僵硬和缄默症被送往急诊科。在病情高峰期,症状包括肌肉僵硬、缄默症、流涎过多、意识水平改变、心动过速、多汗和震颤。通过临床推理、实验室和影像学研究排除了类似疾病后,诊断为非典型抗精神病药恶性综合征(NMS)。他在住院40天期间通过劳拉西泮、金刚烷胺、美索巴莫和支持性护理成功治愈。由于患者未出现发热,该病例代表了NMS的非典型表现。尽管如此,他满足了许多其他标准,最显著的是在接受第一代抗精神病药物治疗后症状迅速出现。该病例还提供了一个机会,来讨论美国被监禁人群中精神疾病的患病率以及监禁作为发生NMS的一个风险因素。

相似文献

1
Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk.一名被监禁患者的非典型抗精神病药恶性综合征:这是一个可能风险增加的人群。
BMJ Case Rep. 2024 Feb 6;17(2):e257563. doi: 10.1136/bcr-2023-257563.
2
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.氟哌啶醇致神经阻滞剂恶性综合征病例的管理挑战。
Neuropsychopharmacol Rep. 2023 Mar;43(1):154-159. doi: 10.1002/npr2.12315. Epub 2022 Dec 30.
3
Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.重新考虑神经安定剂恶性综合征诊断中的僵硬:病例报告。
J Psychiatr Pract. 2020 Jul;26(4):320-323. doi: 10.1097/PRA.0000000000000478.
4
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].[病例报告:抗精神病药恶性综合征及诊断难点]
Encephale. 2016 Jun;42(3):277-80. doi: 10.1016/j.encep.2016.01.001. Epub 2016 Feb 26.
5
Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.与近期抗精神病药引起的神经阻滞剂恶性综合征病史相关,使用丙氯拉嗪引起的神经阻滞剂恶性综合征。
Ann Pharmacother. 2011 Nov;45(11):e61. doi: 10.1345/aph.1Q325. Epub 2011 Oct 4.
6
Neuroleptic malignant syndrome due to olanzapine.奥氮平所致的抗精神病药恶性综合征
Psychopharmacol Bull. 2001 Summer;35(3):49-54.
7
[Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].[抗精神病药恶性综合征:与使用奥氮平相关的复发病例报告]
Arq Neuropsiquiatr. 1998 Dec;56(4):833-7. doi: 10.1590/s0004-282x1998000500022.
8
Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.神经安定剂恶性综合征的诊断与治疗挑战:一个严重的医疗案例。
Riv Psichiatr. 2020 Jul-Aug;55(4):236-239. doi: 10.1708/3417.34000.
9
Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.齐拉西酮诱导的神经阻滞剂恶性综合征的非典型表现:病例报告。
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241262690. doi: 10.1177/23247096241262690.
10
Atypical neuroleptic malignant syndrome - A case report.非典型神经阻滞剂恶性综合征 - 病例报告。
Asian J Psychiatr. 2019 Jun;43:7-8. doi: 10.1016/j.ajp.2019.04.007. Epub 2019 Apr 30.

本文引用的文献

1
Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics.低剂量锂盐所致的神经阻滞剂恶性综合征,无抗精神病药物联用情况
Indian J Psychol Med. 2023 Jan;45(1):92-94. doi: 10.1177/02537176221099307. Epub 2022 Jun 26.
2
Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case.奥卡西平和托吡酯撤药所致的抗精神病药恶性综合征:1例罕见病例
Cureus. 2022 Oct 6;14(10):e29992. doi: 10.7759/cureus.29992. eCollection 2022 Oct.
3
Atypical Neuroleptic Malignant Syndrome in a COVID-19 Intensive Care Unit.新冠重症监护病房中的非典型抗精神病药物恶性综合征
Cureus. 2022 Aug 12;14(8):e27923. doi: 10.7759/cureus.27923. eCollection 2022 Aug.
4
Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status.隐匿性抗精神病药恶性综合征:1例非典型抗精神病药致肌酸激酶升高及精神状态改变的病例报告
Health Psychol Res. 2022 Aug 20;10(3):37530. doi: 10.52965/001c.37530. eCollection 2022.
5
Neuroleptic malignant syndrome in a case of extra-pontine myelinolysis: On the horns of dilemma.桥外髓鞘溶解并发神经安定剂恶性综合征:进退维谷。
Drug Discov Ther. 2022 Jul 20;16(3):145-147. doi: 10.5582/ddt.2021.01012. Epub 2022 Jun 25.
6
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.抗精神病药恶性综合征:一种需多疗法治疗的隐匿性诊断疾病。
BMJ Case Rep. 2019 Jun 17;12(6):e225840. doi: 10.1136/bcr-2018-225840.
7
Care of Incarcerated Patients.监禁患者的护理。
Am Fam Physician. 2018 Nov 15;98(10):577-583.
8
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.抗精神病药恶性综合征:基于临床视角的综述
Curr Neuropharmacol. 2015;13(3):395-406. doi: 10.2174/1570159x13999150424113345.
9
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.第二代抗精神病药物与神经阻滞剂恶性综合征:系统评价与病例报告分析
Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0.
10
Psychoactive Medication Misadventuring in Correctional Health Care.精神活性药物在惩教医疗中的意外情况。
J Correct Health Care. 2014 Jul;20(3):249-260. doi: 10.1177/1078345814532419. Epub 2014 Jun 16.